illustrate the workforce that studies links among cholesterol and the chosen illnesses (Table 1; Figure 8). Not surprisingly key players in the AD field dominate the global rankings (Figures 2, 8). The evaluation shows further that OCs are particularly sensitive for the size of your field. In these with all the lowest variety of articles as well as the smallest workforce (PD, ALS, HD), authors developed maximally 1 offspring indicating that this parameter calls for a crucial mass of authors (Figure 8).The TTP values reveal distinct disease-specific origins from the LPAR5 Molecular Weight leading 10 contributors. Notably, within the AD field, these authors entered the field within one particular decade starting inside the 1990s, whereas, in other fields, these contributors entered immediately after the year 2000 (Figure eight).CONCLUSIONSThe new bibliometric evaluation offers a detailed view from the improvement and structure with the workforce driving investigation on cholesterol and neurodegenerative illnesses and complements content-specific summaries. The analysis revealed that the field began inside the 1950s and remained comparatively modest until the 1990s. Except for MS, all Caspase 9 medchemexpress fields showed intermittent publications, but a strong development considering that 2000. The continuous expansion in the workforce in the course of this period was primarily driven by authors contributing single articles though their contribution varied among the diseases analyzed. More than half of your articles are associated to AD, therefore, the family members ties, collaborative connections, and important players of this field dominate the general picture. The evaluation has caveats. A important challenge for this and also other bibliometric approaches are ambiguous author names, as distinct authors can share precisely the same name precluding right evaluation (Smalheiser and Torvik, 2009). Evaluation of contributions based on single metrics for instance TTP values is context-dependent, unsuited to evaluate junior scientists, and insensitive to ground-breaking contributions from modest teams or from teams that contribute only briefly to a field.AUTHOR CONTRIBUTIONSFWP developed the overview, performed literature queries, wrote and validated the code, analyzed the bibliographic records, ready figures, and wrote the manuscript.FUNDINGThis perform didn’t obtain specific funding. APC had been paid by the author’s institutional funding in the Centre National de la Recherche Scientifique.ACKNOWLEDGMENTSThe author would like to thank Dr. V. Pallottini for beneficial comments on the manuscript.preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J. Neurochem. 69, 1746752. doi: 10.1046/j.1471-4159.1997. 69041746.x Bandres-Ciga, S., Diez-Fairen, M., Kim, J. J., and Singleton, A. B. (2020). Genetics of Parkinson’s disease: an introspection of its journey towards precision medicine. Neurobiol. Dis. 137:104782. doi: 10.1016/j.nbd.2020. 104782 Barboza, L. A., and Ghisi, N. C. (2018). Evaluating the existing state on the art of Huntington illness study: a scientometric evaluation. Braz. J. Med. Biol. Res. 51:e6299. doi: ten.1590/1414-431X
Elbeddini et al. Journal of Pharmaceutical Policy and Practice 14:COMMENTARYOpen AccessImportance of medication reconciliation in cancer patientsAli Elbeddini1 , Anthony To2, Yasamin Tayefehchamani2 and Cindy Xin WenAbstract Cancer patients are a complicated and vulnerable population whose medication history is often extensive. Medication reconciliations in this population are particularly crucial, considering that medication discrepancies c